Sex steroids, growth factors and mammographic density: A cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women

Breast Cancer Research

Volumn 11, Issue 3, 2009, Pages

  McCormack, Valerie A ^a,b   Dowsett, Mitch ^c   Folkerd, Elizabeth ^c   Johnson, Nichola ^d   Palles, Claire ^d   Coupland, Ben ^d   Holly, Jeff M ^e   Vinnicombe, Sarah J ^f   Perry, Nicholas M ^f   Dos Santos Silva, Isabel ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e SOUTHMEAD HOSPITAL   (United Kingdom)

^f ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRONE; GROWTH FACTOR; LEPTIN; PROLACTIN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE; ESTROGEN; HORMONE; SOMATOMEDIN; STEROID;

ADULT; AFRICAN CARIBBEAN; AGE; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; ETHNIC DIFFERENCE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSTMENOPAUSE; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; UNITED KINGDOM; BREAST TUMOR; CENTRAL AMERICA; ETHNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; NEGRO; RADIOGRAPHY;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CARIBBEAN REGION; CROSS-SECTIONAL STUDIES; ESTROGENS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GREAT BRITAIN; HORMONES; HUMANS; MAMMOGRAPHY; MIDDLE AGED; POSTMENOPAUSE; SOMATOMEDINS; STEROIDS;

EID: 74049137235     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2325     Document Type: Article

References (30)

1. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15:1159-1169. 10.1158/1055-9965.EPI-06-0034, 16775176.
2. Martin LJ, Boyd NF. Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 2008, 10:201-216. 2374950, 18226174, 10.1186/bcr1831.
3. Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002, 94:606-616.
4. Renehan AG, Harvie M, Howell A. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer 2006, 13:273-278. 16728563, 16728563, 10.1677/erc.1.01219.
5. Tworoger SS, Eliassen AH, Sluss P, Hankinson SE. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol 2007, 25:1482-1488. 10.1200/JCO.2006.07.6356, 17372279.
6. Hu X, Juneja SC, Maihle NJ, Cleary MP. Leptin - a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 2002, 94:1704-1711.
7. Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med 1999, 130:262-269.
8. Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW. Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 2004, 96:621-628.
9. McCormack VA, Perry N, Vinnicombe SJ, dos Santos Silva I. Ethnic variations in mammographic density: a British multiethnic longitudinal study. Am J Epidemiol 2008, 168:412-421. 10.1093/aje/kwn169, 18621673.
10. Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter J, Ulrich CM, Irwin M, McTiernan A. Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005, 14:1411-1417. 10.1158/1055-9965.EPI-04-0920, 15941949.
11. Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S. The association of breast mitogens with mammographic densities. Br J Cancer 2002, 87:876-882. 10.1038/sj.bjc.6600537, 12373602.
12. Greendale GA, Palla SL, Ursin G, Laughlin GA, Crandall C, Pike MC, Reboussin BA. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. Am J Epidemiol 2005, 162:826-834. 10.1093/aje/kwi286, 16177147.
13. Endogenous Hormones and Breast Cancer Collaborative Group Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values. Cancer Epidemiol Biomarkers Prev 2003, 12:1457-1461. Endogenous Hormones and Breast Cancer Collaborative Group.
14. Allen NE, Roddam AW, Allen DS, Fentiman IS, dos Santos Silva I, Peto J, Holly JM, Key TJ. A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. Br J Cancer 2005, 92:1283-1287. 10.1038/sj.bjc.6602471, 15756268.
15. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol 1994, 39:1629-1638. 10.1088/0031-9155/39/10/008, 15551535.
16. Tamimi RM, Hankinson SE, Colditz GA, Byrne C. Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005, 14:2641-2647. 10.1158/1055-9965.EPI-05-0558, 16284390.
17. Verheus M, Peeters PH, van Noord PA, Schouw YT, Grobbee DE, van Gils CH. No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort. Breast Cancer Res 2007, 9:R53. 2206729, 17692133, 10.1186/bcr1758.
18. Warren R, Skinner J, Sala E, Denton E, Dowsett M, Folkerd E, Healey CS, Dunning A, Doody D, Ponder B, Luben RN, Day NE, Easton D. Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006, 15:1502-1508. 10.1158/1055-9965.EPI-05-0828, 16896040.
19. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature 1983, 303:767-770. 10.1038/303767a0, 6866078.
20. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 2000, 60:3744-3748.
21. dos Santos Silva I, Johnson N, De Stavola B, Torres-Mejia G, Fletcher O, Allen DS, Allen NE, Key TJ, Fentiman IS, Holly JM, Peto J. The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006, 15:449-455. 10.1158/1055-9965.EPI-05-0555, 16537700.
22. Diorio C, Pollak M, Byrne C, Masse B, Hebert-Croteau N, Yaffe M, Coté G, Bérubé S, Morin C, Brisson J. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 2005, 14:1065-1073. 10.1158/1055-9965.EPI-04-0706, 15894654.
23. Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S. The association of breast mitogens with mammographic densities. Br J Cancer 2002, 87:876-882. 10.1038/sj.bjc.6600537, 12373602.
24. Bremnes Y, Ursin G, Bjurstam N, Rinaldi S, Kaaks R, Gram IT. Insulin-like growth factor and mammographic density in postmenopausal Norwegian women. Cancer Epidemiol Biomarkers Prev 2007, 16:57-62. 10.1158/1055-9965.EPI-06-0788, 17220332.
25. Verheus M, Peeters PH, Kaaks R, van Noord PA, Grobbee DE, van Gils CH. Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause. Cancer Epidemiol Biomarkers Prev 2007, 16:451-457. 10.1158/1055-9965.EPI-06-0642, 17372240.
26. Tamimi RM, Cox DG, Kraft P, Pollak MN, Haiman CA, Cheng I, Freedman ML, Hankinson SE, Hunter DJ, Colditz GA. Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study. Breast Cancer Res 2007, 9:R18. 1851377, 17300730, 10.1186/bcr1655.
27. Greendale GA, Huang MH, Ursin G, Ingles S, Stanczyk F, Crandall C, Laughlin GA, Barrett-Connor E, Karlamangla A. Serum prolactin levels are positively associated with mammographic density in postmenopausal women. Breast Cancer Res Treat 2007, 105:337-346. 10.1007/s10549-006-9454-y, 17260098.
28. Bremnes Y, Ursin G, Bjurstam N, Rinaldi S, Kaaks R, Gram IT. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women. Int J Cancer 2007, 121:2506-2511. 10.1002/ijc.22971, 17657735.
29. Tworoger SS, Hankinson SE. Prolactin and breast cancer etiology: an epidemiologic perspective. J Mammary Gland Biol Neoplasia 2008, 13:41-53. 10.1007/s10911-008-9063-y, 18246319.
30. Ginsburg OM, Martin LJ, Boyd NF. Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer 2008, 99:1369-1374. 10.1038/sj.bjc.6604635, 18781174.